Global & Public Health (all articles)
Tests in Recovered Patients Found to be False Positives, Not Reinfections
6 May, 2020 | 03:48h | UTCTests in recovered patients found false positives, not reinfections, experts say – The Korea Herald
See also: Recovered patients who tested positive for COVID-19 likely not reinfected – Live Science AND South Korea says recovered coronavirus patients who tested positive again did not relapse: Tests picked up ‘dead virus fragments’ – Business Insider
Evidence Report: Transmission of SARS-CoV-2 While Presymptomatic or Asymptomatic
6 May, 2020 | 03:43h | UTCRelated: How much is covid-19 spreading via asymptomatic versus symptomatic infections? – The BMJ Opinion
COVID-19: Out-of-control Science and Bypassing Science-based Medicine
5 May, 2020 | 05:04h | UTCCOVID-19: Out-of-control science and bypassing science-based medicine – Science Based Medicine
Related: Covid-19 — A Reminder to Reason – New England Journal of Medicine AND Pandemic Science Out of Control – Issues in Science and Technology AND Science Has an Ugly, Complicated Dark Side. And the Coronavirus Is Bringing It Out – Mother Jones AND Against pandemic research exceptionalism – Science AND In Defense of Evidence-Based Medicine for the Treatment of COVID-19 ARDS – Annals of the American Thoracic Society
Ethical and Legal Challenges of COVID-19 Immunity Certificates
5 May, 2020 | 04:16h | UTCRelated: Covid-19 ‘immunity certificates’: practical and ethical conundrums – STAT AND The Dangerous History of Immunoprivilege – The New York Times AND “COVID-19 ‘Immunity Passports’ and Dystopian Segregation: A Few Concerns” – Bioethics.net
Characteristics of 100 Children with Covid-19
3 May, 2020 | 22:29h | UTCChildren with Covid-19 in Pediatric Emergency Departments in Italy – New England Journal of Medicine
Related Systematic Review: SARS-CoV-2 Infection in Children and Adolescents (study and commentaries)
Report: The Future of the COVID-19 Pandemic – Lessons Learned from Pandemic Influenza
3 May, 2020 | 22:36h | UTCNews Release: COVID-19: The CIDRAP Viewpoint
Public Health Measures and the Reproduction Number of SARS-CoV-2
3 May, 2020 | 22:23h | UTCPublic Health Measures and the Reproduction Number of SARS-CoV-2 – JAMA
Related Editorial: Public Health Interventions for COVID-19: Emerging Evidence and Implications for an Evolving Public Health Crisis – JAMA
Preprint Study Estimates at 10-11 Years That Each of Those Dying of Covid-19 Have Lost
3 May, 2020 | 22:21h | UTCCOVID-19 – exploring the implications of long-term condition type and extent of multimorbidity on years of life lost: a modelling study – Wellcome Open Research (via @EricTopol see Tweet – Thread)
Commentary: Coronavirus deaths ‘result in more than 10 years of life lost per person’ – Express & Star
Offline: A Global Health Crisis? No, Something far Worse
3 May, 2020 | 21:58h | UTCOffline: A global health crisis? No, something far worse – The Lancet
Drive-Through Testing for SARS-CoV-2
3 May, 2020 | 21:54h | UTC
Opinion: Pregnant Women Should be Given the Opportunity to be Included in Clinical Trials for COVID-19
3 May, 2020 | 21:51h | UTC“We recommend and urge the scientific community and professional societies that, without clear justification for exclusion, pregnant women should be given the opportunity to be included in clinical trials for COVID-19 based on the concepts of justice, equity, autonomy, and informed consent.”
New CDC Guidance: Care for Breastfeeding Women with Covid-19
1 May, 2020 | 03:53h | UTCCare for Breastfeeding Women – Centers for Disease Control and Prevention
Study Estimates the Impact of Social Distancing and School Closures on the Dynamics of the COVID-19 Outbreak
1 May, 2020 | 03:39h | UTCChanges in contact patterns shape the dynamics of the COVID-19 outbreak in China – Science
Related Commentary on Twitter
Just published: Major lessons from China on social distancing; school closing; children, young vs. adult impact for #COVID19https://t.co/wd3umeh46m
Social distancing: 7-8 X contact reduction
School closure: 40-60% reduction peak + delay
Continuum of age @ScienceMagazine pic.twitter.com/scrsvF3Pkq— Eric Topol (@EricTopol) April 29, 2020
Study: Within 19 Days After Symptom Onset, 100% of Patients Test Positive for IGG
1 May, 2020 | 03:33h | UTCAntibody responses to SARS-CoV-2 in patients with COVID-19 – Nature Medicine
Commentary: Expert reaction to antibody response in COVID-19 patients – Science Media Centre
Preprint Study Suggests Children May Be as Infectious as Adults
1 May, 2020 | 03:36h | UTC
New Model to Track Covid-19 Spread
1 May, 2020 | 03:29h | UTCPopulation flow drives spatio-temporal distribution of COVID-19 in China – Nature
Commentary: Researchers devise new model to track COVID-19’s spread – Yale News
Perspective: Urging Caution on Remdesivir
1 May, 2020 | 03:07h | UTCUrging Caution On Remdesivir – Forbes
Related: About Remdesivir and About “Game-Changers” – Science Translational Medicine AND Conflicting Remdesivir Trial Results Released; Experts Urge More Research – Health Policy Watch AND Is remdesivir a miracle drug to cure coronavirus? Don’t get your hopes up yet – The Conversation AND PulmCrit- First placebo-controlled RCT on remdesivir for COVID-19 – PulmCrit AND Remdesivir: the antiviral drug is being touted as a possible coronavirus treatment – but will it work? – The Guardian
“While I have enormous respect for the Institutes and their leaders, releasing the preliminary news without sharing the data behind it is highly irresponsible.”
We Need to Flatten the ‘Other’ Coronavirus Curve, Our Looming Mental Health Crisis
1 May, 2020 | 02:45h | UTCRelated: Health Care Workers Seek to Flatten COVID-19’s ‘Second Curve’—Their Rising Mental Anguish
Clinical Determinants for Fatality of 44,672 Patients with COVID-19
1 May, 2020 | 02:48h | UTCClinical determinants for fatality of 44,672 patients with COVID-19 – Critical Care
Randomized Trial: Remdesivir Not Beneficial for Adults with Severe COVID-19
30 Apr, 2020 | 04:31h | UTCCommentaries: First randomized trial of remdesivir suggests antiviral drug is not associated with significant clinical benefits, more research needed – The Lancet AND Expert reaction to trial of remdesivir in adults – Science Media Centre
See also: [Not Published Yet] NIH Study Shows Remdesivir Accelerates Recovery from Advanced COVID-19
Related Commentary on Twitter
With all the hype about Remdesivir today @TheLancet has decided to lift the embargo and release this placebo-controlled multicenter study done in China that showed no benefit https://t.co/ZdmKfnWLyw
— Carlos del Rio (@CarlosdelRio7) April 29, 2020
Pooling of Samples for Testing for SARS-CoV-2 in Asymptomatic People
30 Apr, 2020 | 04:25h | UTCPooling of samples for testing for SARS-CoV-2 in asymptomatic people – The Lancet Infectious Diseases AND Commentary: Virologists show that sample pooling can massively increase coronavirus testing capacity – Saarland University
Related Preprint Study: Smart Pooled sample Testing for COVID-19: A Possible Solution for Sparsity of Test Kits – medRxiv AND Commentary: ‘Smart sample pooling’ for COVID-19 could solve test kit shortage problem – News Medical
[Not Published Yet] NIH Study Shows Remdesivir Accelerates Recovery from Advanced COVID-19
30 Apr, 2020 | 04:28h | UTCCommentaries: Hopes rise on coronavirus drug remdesivir – Nature AND The COVID-19 research news rollercoaster is running again: STAT News + Gilead’s remdesivir – HealthNews Review
See also: Randomized Trial: Remdesivir Not Beneficial for Adults with Severe COVID-19
Audio Interview: Loosening Covid-19 Restrictions
30 Apr, 2020 | 04:17h | UTCAudio Interview: Loosening Covid-19 Restrictions – New England Journal of Medicine
Men with COVID-19 Twice More Likely to Die than Women
30 Apr, 2020 | 04:21h | UTCNews Release: COVID-19 study shows that men have over double the death rate of women – Frontiers
Science Has an Ugly, Complicated Dark Side. And the Coronavirus Is Bringing It Out
30 Apr, 2020 | 04:10h | UTCScience Has an Ugly, Complicated Dark Side. And the Coronavirus Is Bringing It Out – Mother Jones